Efficacy and Safety of an Herbal Therapy in Patients with Amnestic Mild Cognitive Impairment: A 24-Week Randomized Phase III Trial | |
Tian Jinzhou[1]; Shi Jing[2]; Li Tao[3]; Li Lin[4]; Wang Zhiliang[5]; Li Xiaobin[6]; Lv Zhu[7]; Zheng Qingshan[8]; Wei Mingqing[9]; Wang Yongyan[10] | |
刊名 | Evidence-based complementary and alternative medicine : eCAM |
2017 | |
卷号 | 2017页码:4251747 |
ISSN号 | 1741-427X |
URL标识 | 查看原文 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/2224580 |
专题 | 上海大学 |
作者单位 | 1.Third Department of Neurology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China. 2.Department of Neurology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China. 3.Laboratory of Pharmacy, Xuanwu Hospital, Capital University of Medical Sciences, Beijing 100053, China. 4.North China Pharmaceutical Group Corporation, Hebei 050015, China. 5.Drug Clinical Trial Centre, Shanghai University of Chinese Medicine, Shanghai 200032, China. 6.Institute of Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China. |
推荐引用方式 GB/T 7714 | Tian Jinzhou[1],Shi Jing[2],Li Tao[3],et al. Efficacy and Safety of an Herbal Therapy in Patients with Amnestic Mild Cognitive Impairment: A 24-Week Randomized Phase III Trial[J]. Evidence-based complementary and alternative medicine : eCAM,2017,2017:4251747. |
APA | Tian Jinzhou[1].,Shi Jing[2].,Li Tao[3].,Li Lin[4].,Wang Zhiliang[5].,...&Wang Yongyan[10].(2017).Efficacy and Safety of an Herbal Therapy in Patients with Amnestic Mild Cognitive Impairment: A 24-Week Randomized Phase III Trial.Evidence-based complementary and alternative medicine : eCAM,2017,4251747. |
MLA | Tian Jinzhou[1],et al."Efficacy and Safety of an Herbal Therapy in Patients with Amnestic Mild Cognitive Impairment: A 24-Week Randomized Phase III Trial".Evidence-based complementary and alternative medicine : eCAM 2017(2017):4251747. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论